Stock Events

Stock Events

Codexis 

$2.6
60
+$0.11+4.42% Tuesday 20:00

Statistics

Day High
2.6
Day Low
2.5
52W High
3.33
52W Low
0.98
Volume
736,314
Avg. Volume
-
Mkt Cap
234.84M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30JulExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.29
-0.21
-0.12
-0.04
Expected EPS
-0.141667
Actual EPS
N/A

Financials

-109.99%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
118.69MRevenue
-130.55MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CDXS. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zymeworks BC
ZYME
Mkt Cap1.88B
Zymeworks Inc. is involved in the development of biotherapeutics, competing with Codexis in the biocatalyst market for pharmaceuticals.
Evotec
EVO
Mkt Cap1.08B
Evogene Ltd. focuses on the development of products for various life science markets, including the use of computational predictive biology, overlapping with Codexis' enzyme optimization technologies.
BNY Mellon Strategic Municipal Bond Fund
DSM
Mkt Cap0
Koninklijke DSM N.V. is a global science-based company active in health, nutrition, and materials, including biotechnology solutions that compete with Codexis' offerings.
Novonesis AS
NVZMY
Mkt Cap28.02B
Novozymes A/S is a world leader in bioinnovation and industrial enzymes, directly competing with Codexis in the development and production of novel enzymes.
DuPont de Nemours
DD
Mkt Cap19.73B
DuPont de Nemours, Inc. offers technology-based materials, ingredients, and solutions, including biotechnology products that compete with Codexis in the industrial biotech space.
Symrise
SYIEY
Mkt Cap13.06B
Symrise AG is engaged in producing flavors and fragrances, enzymes, and cosmetic ingredients, competing with Codexis in the specialty enzymes market.

About

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Show more...
CEO
Dr. Alison Moore Ph.D.
Employees
188
Country
United States
ISIN
US1920051067

Listings

STU
DE
4QK.STU
F
DE
4QK.F
MU
DE
4QK.MU
XNAS
US
CDXS

0 Comments

Share your thoughts

FAQ

What is Codexis stock price today?▼
The current price of CDXS is $2.6 USD — it has increased by +4.42% in the past 24 hours. Watch Codexis stock price performance more closely on the chart.
What is Codexis stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Codexis stocks are traded under the ticker CDXS.
Is Codexis stock price growing?▼
CDXS stock has risen by +0.78% compared to the previous week, the month change is a -1.89% fall, over the last year Codexis has showed a +1.96% increase.
What is Codexis market cap?▼
Today Codexis has the market capitalization of 234.84M
When is the next Codexis earnings date?▼
Codexis is going to release the next earnings report on July 30, 2026.
What were Codexis earnings last quarter?▼
CDXS earnings for the last quarter are -0.1 USD per share, whereas the estimation was -0.14 USD resulting in a +26.83% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Codexis revenue for the last year?▼
Codexis revenue for the last year amounts to 118.69M USD.
What is Codexis net income for the last year?▼
CDXS net income for the last year is -130.55M USD.
How many employees does Codexis have?▼
As of May 27, 2026, the company has 188 employees.
In which sector is Codexis located?▼
Codexis operates in the Health & Wellness sector.
When did Codexis complete a stock split?▼
Codexis has not had any recent stock splits.
Where is Codexis headquartered?▼
Codexis is headquartered in Redwood City, United States.